Literature DB >> 33904776

Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening.

Giuseppe Petralia1, Dow-Mu Koh1, Raj Attariwala1, Joseph J Busch1, Ros Eeles1, David Karow1, Gladys G Lo1, Christina Messiou1, Evis Sala1, Hebert A Vargas1, Fabio Zugni1, Anwar R Padhani1.   

Abstract

Acknowledging the increasing number of studies describing the use of whole-body MRI for cancer screening, and the increasing number of examinations being performed in patients with known cancers, an international multidisciplinary expert panel of radiologists and a geneticist with subject-specific expertise formulated technical acquisition standards, interpretation criteria, and limitations of whole-body MRI for cancer screening in individuals at higher risk, including those with cancer predisposition syndromes. The Oncologically Relevant Findings Reporting and Data System (ONCO-RADS) proposes a standard protocol for individuals at higher risk, including those with cancer predisposition syndromes. ONCO-RADS emphasizes structured reporting and five assessment categories for the classification of whole-body MRI findings. The ONCO-RADS guidelines are designed to promote standardization and limit variations in the acquisition, interpretation, and reporting of whole-body MRI scans for cancer screening. Published under a CC BY 4.0 license Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2021        PMID: 33904776     DOI: 10.1148/radiol.2021201740

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM/MUKnine multi-centre clinical trial for patients with myeloma.

Authors:  Mihaela Rata; Matthew Blackledge; Erica Scurr; Jessica Winfield; Dow-Mu Koh; Alina Dragan; Antonio Candito; Alexander King; Winston Rennie; Suchi Gaba; Priya Suresh; Paul Malcolm; Amy Davis; Anjumara Nilak; Aarti Shah; Sanjay Gandhi; Mauro Albrizio; Arnold Drury; Sadie Roberts; Matthew Jenner; Sarah Brown; Martin Kaiser; Christina Messiou
Journal:  Insights Imaging       Date:  2022-07-28

2.  Radiologic screening and surveillance in hereditary cancers.

Authors:  Jamie E Clarke; Stephanie Magoon; Irman Forghani; Francesco Alessandrino; Gina D'Amato; Emily Jonczak; Ty K Subhawong
Journal:  Eur J Radiol Open       Date:  2022-04-25

3.  Effects of Sex and Age on Fat Fraction, Diffusion-Weighted Image Signal Intensity and Apparent Diffusion Coefficient in the Bone Marrow of Asymptomatic Individuals: A Cross-Sectional Whole-Body MRI Study.

Authors:  Alberto Colombo; Luca Bombelli; Paul E Summers; Giulia Saia; Fabio Zugni; Giulia Marvaso; Robert Grimm; Barbara A Jereczek-Fossa; Anwar R Padhani; Giuseppe Petralia
Journal:  Diagnostics (Basel)       Date:  2021-05-20

Review 4.  Whole-body magnetic resonance imaging (WB-MRI) for cancer screening: recommendations for use.

Authors:  Giuseppe Petralia; Fabio Zugni; Paul E Summers; Alberto Colombo; Paola Pricolo; Luigi Grazioli; Stefano Colagrande; Andrea Giovagnoni; Anwar R Padhani
Journal:  Radiol Med       Date:  2021-08-02       Impact factor: 3.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.